Blood Cancer Discovery
@BCD_AACR
Follow Blood Cancer Discovery for high-impact articles on pace-setting advances of researchers and physician-scientists working globally. Published by @AACR.
#ICYMI Single-cell Resolved Oncogene Co-expression: From Principles to Clinical Impact brnw.ch/21wUmMz #hemepath #hemeonc #bloodcancers
#ICYMI The Silence of the Lambdas: Hidden Complexities in the Evolution of Double-Hit Lymphomas brnw.ch/21wUkUn
ICYMI: Putting AML Differentiation States on the BoneMarrowMap brnw.ch/21wUj48 @livius_tacitus
Keep up with the latest Blood Cancer Discovery issues by getting alerts sent directly to your inbox. Sign up: brnw.ch/21wUfPY
ICYMI: Q&A with Louis Staudt on Molecular Classification of Cancer brnw.ch/21wUfEz
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements: brnw.ch/21wUdLW #lymphoma #DLBCL #bcellmalignancies @Lymphoma_Papers
Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q: brnw.ch/21wUc0Q #AMLsm
DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features: brnw.ch/21wUa6K #lymsm #lymphoma @Lymphoma_Papers
Online First: Microbiota shape metabolic and immune determinants of CAR-T therapy and correlate with outcomes in myeloma brnw.ch/21wU8Gz
Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Differentiation: brnw.ch/21wU8hL @andygxzeng @PMResearch_UHN #AMLsm
Blood Cancer Discovery in the news: Real-world Data Shows Teclistamab Can Benefit Many Multiple Myeloma Patients Who Would Have Been Ineligible for Pivotal Trial Be sure to check out the Online First article and press release: brnw.ch/21wU56U brnw.ch/21wU56T
Clinical Significance of TP53-Mutant Clonal Hematopoiesis Across Diseases: brnw.ch/21wU4TA #CHIPsm #clonalhematopoiesis
Overcoming B-ALL Resistance to Targeted and Immune Therapies by Rational Combination Strategies: brnw.ch/21wU2WY @Elvin_Wag
Online First: Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency brnw.ch/21wU1Au
Online First: An isoform-specific RUNX1C–BTG2 axis governs AML quiescence and chemoresistance. brnw.ch/21wU1As
Single-cell Resolved Oncogene Co-expression: From Principles to Clinical Impact brnw.ch/21wU14e #hemepath #hemeonc #bloodcancers
Online First: Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium brnw.ch/21wU0NM
The Silence of the Lambdas: Hidden Complexities in the Evolution of Double-Hit Lymphomas brnw.ch/21wTZcq
In the Spotlight: Putting AML Differentiation States on the BoneMarrowMap brnw.ch/21wTXqZ @livius_tacitus
Online First: Multi-Modal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification Across Disease States brnw.ch/21wTSQI
